Article
Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
Journal of the American College of Cardiology - 26 Apr 2022
Mohammadi-Shemirani Pedrum, Chong Michael, Narula Sukrit, Perrot Nicolas, Conen David, Roberts Jason D, Thériault Sébastien, Bossé Yohan, Lanktree Matthew B, Pigeyre Marie, Paré Guillaume
Abstract excerpt
BACKGROUND: Atrial fibrillation (AF) is a cardiac arrhythmia associated with an elevated risk of stroke, heart failure, and mortality. However, preventative therapies are needed with ancillary benefits on its cardiovascular comorbidities. Lipoprotein(a) (Lp[a]) is a recognized risk factor for atherosclerotic cardiovascular disease (ASCVD), which itself increases AF risk, but it remains unknown whether Lp(a) is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
